Govt Job for M.Pharm, M.Sc under Dept of Science and Technology

Jamia Hamdard was conceived as a seat of higher learning in Unani Medicine, Islamic Studies, Biosciences, Pharmacy, Nursing and other areas of knowledge by its founder as a means of fulfilling the objects of the wakf.

Over a period of last ten years, Jamia Hamdard has emerged as an outstanding institution of higher learning with distinct and focused academic programmes.

Graduate programme in Information Technology and Computer Applications and Post-graduate programmes in Information Technology, Computer Applications, Business Management, Physiotherapy and Occupational Therapy have been started in the last few years.

ADVERTISEMENT FOR JUNIOR RESEARCH FELLOW IN THE RESEARCH PROJECT SPONSORED BY SERB, DEPARTMENT OF SCIENCE & TECHNOLOGY, GOVT. OF INDIA

Tile of Project: “Cognitive remediation through Behavioral Reinforcement in Traumatic Brain Injury”

Essential qualifications :

M.Sc. Toxicology or M.Pharm. (Pharmacology) with first division
Qualified NET – JRF/LS examination of CSIR/UGC/ICMR for M.Sc. applicants or GATE for M.Pharm. applicants

Desirable : Experience in surgical models of rodents

Duration of appointment : Initially for a period of one year

Candidates fulfilling the eligibility criteria may submit the application along with recent CV and other relevant documents to the Principal Investigator, Prof. Suhel Parvez, Head, Department of Medical Elementology & Toxicology, School of Chemical and Life Sciences, Jamia Hamdard, Hamdard Nagar, New Delhi 110062 only by email (sparvez@jamiahamdard.ac.in).

Last date of receipt of applications is 19th April 2021.

Only short-listed candidates will be called for an interview.

Related Posts

Apollo Navi Mumbai launches geriatric oncology clinic

With a dedicated Geriatric Oncology Clinic, Apollo Hospitals Navi Mumbai brings specialised geriatric cancer care to the private healthcare setting in Navi Mumbai. With the launch of the Geriatric Oncology…

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Mumbai: The Food and Drug Administration (FDA) has cracked down on medical stores violating drug-sale rules, suspending 599 licences and cancelling another 141 after inspecting 2,295 retail establishments across the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Apollo Navi Mumbai launches geriatric oncology clinic

Apollo Navi Mumbai launches geriatric oncology clinic

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Maharashtra FDA cancels licences of 62 pharma units, 141 chemist shops

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Himachal DCA honoured with ‘Regulatory Excellence Award’ at iPHEX 2026

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

Baddi pharma firm loses licence after 1,200-kg tapentadol haul

US FDA takes steps to maintain newborn access to life-saving starter nutrition products

US FDA takes steps to maintain newborn access to life-saving starter nutrition products

Mankind Pharma launches campaign to inspire 1 crore Indians to pledge for organ donation